Share this Article
You are free to share this article under the Attribution 4.0 International license.
A new method for interpreting brain waves could potentially help determine the best depression treatment, according to a new study.
The researchers used electroencephalography, a tool for monitoring electrical activity in the brain, and an algorithm to identify a brain-wave signature in individuals with depression who will most likely respond to sertraline, an antidepressant marketed as Zoloft.
The study emerged from a decades-long effort to create biologically based approaches, such as blood tests and brain imaging, to help personalize the treatment of depression and other mental disorders. Currently, there are no such tests to objectively diagnose depression or guide its treatment.
This study takes previous research showing that we can predict who benefits from an antidepressant and actually brings it to the point of practical utility, says Amit Etkin, professor of psychiatry and behavioral sciences at Stanford University. I will be surprised if this isnt used by clinicians within the next five years.
Instead of functional magnetic resonance imaging, an expensive technology often used in studies to image brain activity, the scientists turned to electroencephalography, or EEG, a much less costly technology.
The paper is one of several based on data from a federally funded depression study launched in 2011the largest randomized, placebo-controlled clinical trial on antidepressants ever conducted with brain imagingwhich tested the use of sertraline in 309 medication-free patients.
The trial was called Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care, or EMBARC. The researchers designed the trial to advance the goal of improving the trial-and-error method of treating depression that is still in use today.
It often takes many steps for a patient with depression to get better, says co-senior author Madhukar Trivedi, professor of psychiatry at the University of Texas-Southwestern who led the research team.
We went into this thinking, Wouldnt it be better to identify at the beginning of treatment which treatments would be best for which patients?'
Major depression is the most common mental disorder in the United States, affecting about 7% of adults in 2017, according to the National Institute of Mental Health (NIMH). Among those, about half never get diagnosed.
For those who do, finding the right treatment can take years, Trivedi says. He points to one of his past studies that showed only about 30% of patients with depression saw any remission of symptoms after their first treatment with an antidepressant.
Current methods for diagnosing depression are simply too subjective and imprecise to guide clinicians in quickly identifying the right treatment, Etkin says. In addition to a variety of antidepressants, there are several other types of treatments for depression, including psychotherapy and brain stimulation, but figuring out which treatment will work for which patients is based on educated guessing.
To diagnose depression, clinicians rely on a patient reporting at least 5 of 9 common symptoms of the disease. The list includes symptoms such as feelings of sadness or hopelessness, self-doubt, sleep disturbancesranging from insomnia to sleeping too muchlow energy, unexplained body aches, fatigue, and changes in appetite, ranging from overeating to undereating. Patients often vary in both the severity and types of symptoms they experience, Etkin says.
As a psychiatrist, I know these patients differ a lot, Etkin says. But we put them all under the same umbrella, and we treat them all the same way.
Treating people with depression often begins with prescribing them an antidepressant. If one doesnt work, a second antidepressant is prescribed. Each of these trials often takes at least eight weeks to assess whether the drug worked and symptoms are alleviated.
If an antidepressant doesnt work, other treatments, such as psychotherapy or occasionally transcranial magnetic stimulation, may work. Often, doctors combine multiple treatments, Etkin says, but figuring out which combination works can take a while.
People often feel a lot of dejection each time a treatment doesnt work, creating more self-doubt for those whose primary symptom is most often self-doubt, Trivedi says.
The EMBARC trial enrolled 309 people with depression who randomly received either sertraline or a placebo.
For their study, Etkin and his colleagues set out to find a brain-wave pattern to help predict which depressed participants would respond to sertraline. First, the researchers collected EEG data on the participants before they received any drug treatment. The goal was to obtain a baseline measure of brain-wave patterns.
Next, using insights from neuroscience and bioengineering, the investigators analyzed the EEG using a novel artificial intelligence technique they developed and identified signatures in the data that predicted which participants would respond to treatment based on their individual EEG scans.
The researchers found that this technique reliably predicted which of the patients did, in fact, respond to sertraline and which responded to placebo. They replicated the results at four different clinical sites.
Further research suggests that participants who researchers predicted would show little improvement with sertraline were more likely to respond to treatment involving transcranial magnetic stimulation, or TMS, in combination with psychotherapy.
Using this method, we can characterize something about an individual persons brain, Etkin says. Its a method that can work across different types of EEG equipment, and thus more apt to reach the clinic.
Part of getting these study results used in clinical care is, I think, that society has to demand it, Trivedi says. That is the way things get put into practice. I dont see a downside to putting this into clinical use soon.
When researchers launched EMBARC, it was part of a broader effort by the NIMH to push for improvements in mental health care by using advances in fields such as genetics, neuroscience, and biotechnology, says Thomas Insel, who served as director of that institute from 2002 to 2015.
We went into EMBARC saying anything is possible, Insel says. Lets see if we can come up with clinically actionable techniques. He didnt think it would take this long, but he remains optimistic.
I think this study is a particularly interesting application of EMBARC, he says. It leverages the power of modern data science to predict at the individual level who is likely to respond to an antidepressant.
In addition to improving care, the researchers say they see a possible side benefit to the use of biologically based approaches: It could reduce the stigma associated with depression and other mental health disorders that prevents many people from seeking appropriate medical care.
Id love to think scientific evidence will help to counteract this stigma, but it hasnt so far, says Insel. Its been over 160 years since Abraham Lincoln says that melancholy is a misfortune, not a fault. We still have a long way to go before most people will understand that depression is not someones fault. (President Lincoln suffered bouts of depression.)
A paper on the work appears in Nature Biotechnology. Additional researchers from South China University of Technology, the Netherlands Research Institute, Harvard Medical School, the New York State Psychiatric Institute, Columbia University, and the Netherlands neuroCare Group contributed to the work.
Etkin is on leave from Stanford, working as the founder and CEO of the startup Alto Neuroscience, a company based in Los Altos, California that aims to build on these findings and develop a new generation of biologically based diagnostic tests to personalize mental health treatments with a high degree of clinical utility. Insel is an investor in Alto Neuroscience.
Funding came from the National Institutes of Health, the Stanford Neurosciences Institute, the Hersh Foundation, the National Key Research and Development Plan of China, and the National Natural Science Foundation of China.
Source: Stanford University
Read the original post:
Brain waves show who'll respond to Zoloft - Futurity: Research News
- Elusive Cures: Why Neuroscience Hasnt Solved Brain Disordersand How We Can Change That, an excerpt - The Transmitter - June 10th, 2025 [June 10th, 2025]
- Nanowire Retinal Implant Restores Vision and Sees Infrared - Neuroscience News - June 10th, 2025 [June 10th, 2025]
- KLOTHO NEUROSCIENCE, INC. ANNOUNCES AN APPROACH TO INCREASE LONGEVITY AND HEALTHY LIFE SPAN - REPLACE A SILENCED GENE CALLED ALPHA-KLOTHO... - June 10th, 2025 [June 10th, 2025]
- Obeying Orders Lowers Moral Responsibility Perception in the Brain - Neuroscience News - June 10th, 2025 [June 10th, 2025]
- Family Time and Parental Bonding Linked to Better Sleep in Preteens - Neuroscience News - June 10th, 2025 [June 10th, 2025]
- Study Links Gut Bacteria to MS Risk and Reveals Key Triggers - Neuroscience News - June 10th, 2025 [June 10th, 2025]
- Alto Neuroscience Announces Acquisition of Novel Dopamine Agonist Combination Product Candidate, Adding Late-Stage Readout in Treatment Resistant... - June 10th, 2025 [June 10th, 2025]
- Sleep-Wake Perception Intact in Many With Insomnia - Neuroscience News - June 10th, 2025 [June 10th, 2025]
- Cannabis Use Among U.S. Seniors Has Surged 46% in Just Two Years - Neuroscience News - June 10th, 2025 [June 10th, 2025]
- Anoki Integrates With Magnite While Seedtag Adds Neuroscience To Find Emotional Connections - TVREV - June 10th, 2025 [June 10th, 2025]
- Neuroscience: Knowing People's Names Makes You Empathize With Them Better. (By the Way, My Name Is Bill) - Inc.com - June 1st, 2025 [June 1st, 2025]
- Kindness Sparks Cooperation by Boosting Social Connectedness - Neuroscience News - June 1st, 2025 [June 1st, 2025]
- Neuroscience and Genetics of ADHD and Neurodevelopment - Neuroscience News - June 1st, 2025 [June 1st, 2025]
- The Neuroscience of Cancer - Harvard Medicine Magazine - June 1st, 2025 [June 1st, 2025]
- Singing to Infants Boosts Mood and Bonding - Neuroscience News - June 1st, 2025 [June 1st, 2025]
- Neuroscience: Go Swimming and Your Brain Will Thank You - Inc.com - June 1st, 2025 [June 1st, 2025]
- Blood Fat Links Found Between Heart Risk and Alzheimers - Neuroscience News - June 1st, 2025 [June 1st, 2025]
- Tiny Brain Cell Cluster Found to Drive Obesity and Overeating - Neuroscience News - June 1st, 2025 [June 1st, 2025]
- New Neuroscience Shows Why Its So Important to Read Aloud to Your Kids - Inc.com - June 1st, 2025 [June 1st, 2025]
- Cats Can Recognize Their Owners by Smell Alone - Neuroscience News - June 1st, 2025 [June 1st, 2025]
- St. Lukes Center for Neuroscience Helps Those with Same Illness as Billy Joel - TAPinto - June 1st, 2025 [June 1st, 2025]
- These triplets who graduated from Georgia Tech with neuroscience degrees head to medical school - 11Alive.com - June 1st, 2025 [June 1st, 2025]
- Gabe Newell co-founded a neuroscience company in 2019 and its first brain chip is expected to ship later this year - PC Gamer - June 1st, 2025 [June 1st, 2025]
- Next-Gen Painkiller Blocks Pain Without the High - Neuroscience News - May 21st, 2025 [May 21st, 2025]
- Inflammation Triggers Repetitive Behaviors in ASD and OCD - Neuroscience News - May 21st, 2025 [May 21st, 2025]
- Astrocytes Take Center Stage in Brain Function and Behavior - Neuroscience News - May 21st, 2025 [May 21st, 2025]
- Setting the SCENE for Neuroscience Breakthroughs - Mellon College of Science - Carnegie Mellon University - May 21st, 2025 [May 21st, 2025]
- Long COVID Brain Fog Linked to Inflammation and Stress Markers - Neuroscience News - May 21st, 2025 [May 21st, 2025]
- Warren Buffett Says Youre Too Focused on the Negative. Heres the Neuroscience Showing Hes Right - Inc.com - May 21st, 2025 [May 21st, 2025]
- Reading Fiction Boosts Empathy and Fights Loneliness - Neuroscience News - May 21st, 2025 [May 21st, 2025]
- Astrocytes, Not Neurons, Drive Brains Attention and Alertness - Neuroscience News - May 21st, 2025 [May 21st, 2025]
- Mapping Young Minds: The Neuroscience Behind Babilou Family Singapore's Revolutionary Education Model - PR Newswire - May 21st, 2025 [May 21st, 2025]
- Loneliness Linked to 24% Higher Risk of Hearing Loss - Neuroscience News - May 21st, 2025 [May 21st, 2025]
- Eureka Moments Double Memory by Rewiring the Brain - Neuroscience News - May 21st, 2025 [May 21st, 2025]
- Scientists use brain activity to predict StarCraft II skill in fascinating new neuroscience research - psypost.org - May 21st, 2025 [May 21st, 2025]
- Stress of Long Work Hours May Physically Alter the Brain - Neuroscience News - May 21st, 2025 [May 21st, 2025]
- The Neuroscience of Dopamine: How to Triumph Over Constant Wanting - Next Big Idea Club - May 12th, 2025 [May 12th, 2025]
- Verbal Abuse in Childhood Rewires the Developing Brain - Neuroscience News - May 12th, 2025 [May 12th, 2025]
- Heavy Social Media Use Linked to Believing and Spreading Fake News - Neuroscience News - May 12th, 2025 [May 12th, 2025]
- Brain Cells That Predict What Comes Next, Even When Its New - Neuroscience News - May 12th, 2025 [May 12th, 2025]
- The Temperature | Better happiness through neuroscience - The Colorado Sun - May 12th, 2025 [May 12th, 2025]
- Genes Strongly Influence When Babies Take Their First Steps - Neuroscience News - May 12th, 2025 [May 12th, 2025]
- Using Music to Detect Concussion in Kids - Neuroscience News - May 12th, 2025 [May 12th, 2025]
- Boosting Klotho Protein Slows Aging and Enhances Health - Neuroscience News - May 12th, 2025 [May 12th, 2025]
- Eye Movements Set the Speed Limit for What You Can See - Neuroscience News - May 12th, 2025 [May 12th, 2025]
- Seeing Is Believing: How We Judge AI as Creative or Not - Neuroscience News - May 12th, 2025 [May 12th, 2025]
- Exercise Boosts Stem Cell Therapy for Parkinsons - Neuroscience News - May 12th, 2025 [May 12th, 2025]
- Aspen Neuroscience Announces 6-Month ASPIRO Phase 1/2a Clinical Trial Results of Personalized Cell Therapy for Parkinson's Disease - BioSpace - May 12th, 2025 [May 12th, 2025]
- Sheffield Lab: Understanding the neuroscience of memories - University of Chicago News - April 27th, 2025 [April 27th, 2025]
- Prenatal Stress Leaves Lasting Molecular Imprints on Babies - Neuroscience News - April 27th, 2025 [April 27th, 2025]
- Dean Buonomano explores the concept of time in neuroscience and physics - The Transmitter - April 27th, 2025 [April 27th, 2025]
- Psychedelics May Reset Brain-Immune Link Driving Fear and Anxiety - Neuroscience News - April 27th, 2025 [April 27th, 2025]
- Infant Social Skills Thrive Despite Hardship - Neuroscience News - April 27th, 2025 [April 27th, 2025]
- From Cologne to Country Roads: One scientist's interdisciplinary journey to build bridges (and robotic insects) between neuroscience and engineering -... - April 27th, 2025 [April 27th, 2025]
- Eyes Reveal Intentions Faster Than We Think - Neuroscience News - April 27th, 2025 [April 27th, 2025]
- Immune Resilience Identified as Key to Healthy Aging and Longevity - Neuroscience News - April 27th, 2025 [April 27th, 2025]
- Energy Starvation Triggers Dangerous Glutamate Surges in the Brain - Neuroscience News - April 27th, 2025 [April 27th, 2025]
- WVU Rockefeller Neuroscience Institute first in U.S. to successfully test innovative brain-computer interface technology to decode speech and language... - April 27th, 2025 [April 27th, 2025]
- Microglia Reprogrammed to Deliver Precision Alzheimers Therapies - Neuroscience News - April 27th, 2025 [April 27th, 2025]
- Neuroscience Says Music Is an Emotion Regulation Machine. Heres What to Play for Happiness, Productivity, or Deep Thinking - Inc.com - April 19th, 2025 [April 19th, 2025]
- Early Maternal Affection Shapes Key Personality Traits for Life - Neuroscience News - April 19th, 2025 [April 19th, 2025]
- Elons new neuroscience major highlighted by Greensboro News & Record - Elon University - April 19th, 2025 [April 19th, 2025]
- Brain Blast event at St. Lawrence University teaches local students neuroscience - North Country Now - April 19th, 2025 [April 19th, 2025]
- AI Reveals What Keeps People Committed to Exercise - Neuroscience News - April 19th, 2025 [April 19th, 2025]
- The "Holy Grail" of Neuroscience? Researchers Create Stunningly Accurate Digital Twin of the Brain - The Debrief - April 19th, 2025 [April 19th, 2025]
- Annenberg School Vice Dean Emily Falk publishes book on the neuroscience of decision-making - The Daily Pennsylvanian - April 19th, 2025 [April 19th, 2025]
- Music-Induced Chills Trigger Natural Opioids in the Brain - Neuroscience News - April 19th, 2025 [April 19th, 2025]
- What We Value: The Neuroscience of Choice and Change - think.kera.org - April 19th, 2025 [April 19th, 2025]
- Kile takes top neuroscience post at Sutter Health as system pushes to align care, expand trials - The Business Journals - April 19th, 2025 [April 19th, 2025]
- A Grain of Brain, 523 Million Synapses, and the Most Complicated Neuroscience Experiment Ever Attempted - SciTechDaily - April 19th, 2025 [April 19th, 2025]
- Mild Brain Stimulation Alters Decision-Making Speed and Flexibility - Neuroscience News - April 19th, 2025 [April 19th, 2025]
- Cannabis studies were informing fundamental neuroscience in the 1970s - Nature - April 10th, 2025 [April 10th, 2025]
- To make a meaningful contribution to neuroscience, fMRI must break out of its silo - The Transmitter - April 10th, 2025 [April 10th, 2025]
- Steve Jobss Unexpected Secret to Being More Creative (Backed by Neuroscience) - Inc.com - April 10th, 2025 [April 10th, 2025]
- Challenging Decades of Neuroscience: Brain Cells Are More Plastic Than Previously Thought - SciTechDaily - April 10th, 2025 [April 10th, 2025]
- Q&A: Lundbecks head of R&D on letting biology speak in neuroscience - Endpoints News - April 10th, 2025 [April 10th, 2025]
- Why it's hard to study the neuroscience of psychedelics : Short Wave - NPR - April 10th, 2025 [April 10th, 2025]
- Fear Sync: How Males and Females Respond to Stress Together - Neuroscience News - April 10th, 2025 [April 10th, 2025]
- Chemotherapy Disrupts Brain Connectivity - Neuroscience News - April 10th, 2025 [April 10th, 2025]
- Newly awarded NIH grants for neuroscience lag 77 percent behind previous nine-year average - The Transmitter - April 10th, 2025 [April 10th, 2025]